Veradermics MANE
NYSE MANE
$98.31 +0.56 (+0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Veradermics (MANE) Treasury Shares (2024 - 2025)

Veradermics' (MANE) quarterly Treasury Shares came in at $12.9 million in Q4 2025, little changed on a QoQ basis from $12.9 million in Q1 2025.

Analysis

Veradermics (MANE) Treasury Shares (2024 - 2025) Analysis & Trends

Veradermics (MANE) has 1 years of Treasury Shares data on file, last reported at $12.9 million in Q4 2025.

  • Quarterly Treasury Shares changed N/A year-over-year to $12.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.9 million (changed N/A YoY) and the FY2025 annual result came in at $118.7 million, up 114.82% from the prior year.
  • Treasury Shares held at $12.9 million in Q4 2025, from $12.9 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $12.9 million in Q1 2025 to a low of $12.9 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 2.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Veradermics 3.96 Bn 3.96 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 118.68 Mn
Dec 31, 2025 118.68 Mn
Jun 30, 2025 62.25 Mn
Jun 30, 2025 62.25 Mn
Mar 31, 2025 62.25 Mn
Mar 31, 2025 62.25 Mn
Dec 31, 2024 55.25 Mn
Dec 31, 2024 55.25 Mn